ArticleArchives of endocrinology and metabolism2025

BRAF inhibitor or BRAF/MEK inhibitor treatment for patients with metastatic BRAF V600E mutated differentiated thyroid cancer.

Inbar Finkel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.